Sector Pulse — March 11, 2026

Technology

Theme: AI infrastructure spending remains the sector’s dominant earnings and capital allocation engine, but leadership is concentrating in companies with tangible revenue, backlog, and ecosystem control rather than concept-driven narratives. The day’s news reinforced a widening split between real infrastructure enablers, profitable software/platform beneficiaries, and speculative names facing valuation or execution scrutiny.

Movers:

AVGO, Broadcom — AI semiconductor revenue surged 106% year over year, with hyperscaler demand and networking exposure reinforcing Broadcom’s case as a credible alternative pillar to Nvidia in AI infrastructure. This matters because it broadens the AI supply chain leadership set beyond GPUs and supports a structural re-rating of custom silicon and networking names.
DELL, Dell Technologies — Dell’s $43 billion AI server backlog and expected 103% AI server sales growth underscore that it is becoming a core systems integrator for enterprise AI deployment, not just a commodity hardware vendor. The scale of backlog gives investors unusually strong visibility into AI infrastructure monetization.
ORCL, Oracle — Oracle’s quarter marked a clear step-function higher in AI/cloud credibility, with AI infrastructure revenue up sharply, multicloud growth exploding, and long-term revenue guidance raised to $90 billion. The importance is that Oracle is moving from legacy software perception to a capital-intensive but highly relevant AI cloud platform winner.
CRWD, CrowdStrike — CrowdStrike delivered its first positive quarterly net income alongside record ARR, showing the company has crossed from pure growth story into scalable, profitable cybersecurity platform territory. That shifts the debate from “can it monetize?” to how much strategic upside remains from cloud and sovereign security demand.
CSCO, Cisco — Cisco’s $2.1 billion of hyperscaler AI orders in a single quarter is a notable proof point that legacy networking incumbents can still win in AI buildouts if they control key enterprise and data-center plumbing. It matters because it supports the thesis that AI capex is lifting more of the stack than just semis.
ADBE, Adobe — Adobe’s expanding MLB AI partnership and steady earnings setup reinforce its effort to become an enterprise-grade generative content platform, not just a creative software vendor. That matters because it gives Adobe a visible case study for commercial AI monetization in media and marketing workflows.
GOOGL, Alphabet — The combination of 48% Google Cloud growth, deep AI infrastructure partnerships, and continued enterprise AI deployments reinforces Alphabet’s positioning as a monetizing AI platform rather than a narrative stock. Investor attention remains on whether cloud can keep converting AI demand into sustained margin expansion.
MSFT, Microsoft — Microsoft remains one of the clearest examples of AI spending translating into real cloud demand, and commentary around valuation suggested the stock is being underappreciated relative to its infrastructure role. The key takeaway is that Microsoft still looks like a core AI compounder rather than a fully exhausted trade.
PLTR, Palantir — Discussion around Palantir versus weaker AI names reinforced the market’s preference for profitable, execution-led AI exposure. This matters as capital continues rotating away from cash-burning “AI stories” toward software names proving commercial utility and margins.
AI, C3.ai — C3.ai’s continued deterioration versus stronger AI peers reinforced the market’s intolerance for weak billings, shrinking margins, and narrative without economics. It matters because C3.ai has become a negative read-through for lower-quality AI software.
SNOW, Snowflake — Snowflake remains a key AI data-layer asset, but litigation and governance overhangs are competing with the AI platform story. The broader read-through is that AI adjacency alone is no longer enough if transparency and execution are questioned.
NET, Cloudflare — Cloudflare’s AI and edge-infrastructure narrative remains strong, but valuation concerns are becoming the central investor debate. This matters because premium AI infrastructure software is entering a phase where multiples are being tested against actual monetization.
SHOP, Shopify — Shopify’s valuation disconnect remains extreme, with bulls focused on platform leverage and bears focused on pricing in perfection. The implication is that software names exposed to AI and commerce still need to prove sustainable economics, not just strategic relevance.
CHGG, Chegg — Chegg’s nearly 50% revenue collapse is one of the clearest examples of AI disruption creating outright losers. It matters because it shows how quickly undifferentiated digital content businesses can be disintermediated.

Watch:

NVDA, Nvidia ecosystem demand and supply-chain breadth — today’s reports from suppliers and partners suggest AI capex remains broadening, but the key forward question is whether that demand sustains beyond hyperscaler front-loading.
Enterprise AI monetization across NOW, SNOW, DDOG, HUBS, and DOCU — investors will increasingly reward names that show AI-linked upsell, retention, and margin durability, not just product launches.

Financials

Theme: The dominant narrative in financials was a sharp divide between quality franchises with earnings momentum and capital discipline, and pockets of mounting stress in private credit, regional banking, and select asset managers. At the same time, firms tied to digital infrastructure, private markets, and capital returns continued to attract investor focus.

Movers:

JPM, JPMorgan Chase — JPMorgan’s markdown of software-linked private credit collateral is the clearest signal yet that private credit is entering a tougher valuation and underwriting phase. This matters because JPM is effectively setting the tone for risk repricing across the broader alternative credit ecosystem.
BX, Blackstone — Blackstone’s internal support for redemptions and wider private credit stress reinforced concerns that liquidity mismatches are no longer theoretical in private markets. This is important because Blackstone often serves as a sentiment anchor for alternatives, and strain here can spread quickly to peers and fundraising conditions.
APO, Apollo Global Management — Apollo’s continued exposure to stressed software credit made it a key read-through on the sector’s vulnerability. Investors are increasingly focused on whether private credit managers can defend marks and liquidity if defaults rise.
ARES, Ares Management — Ares remains a central casualty of the private credit markdown story, with shares reacting to concerns around software-backed lending. This matters as Ares is viewed as a bellwether for institutional private credit appetite.
KKR, KKR — KKR’s exposure to software-heavy private credit added to the broader stress narrative in alternatives. The implication is that strong fundraising alone won’t insulate firms from mark-to-market or underwriting pressure.
GS, Goldman Sachs — Goldman’s continued strategic breadth in capital markets and infrastructure looked constructive, but former leadership’s warning on private credit embedded in retirement products added another layer of systemic concern. This matters because it broadens private credit worries from institutional balance sheets to retail and retirement channels.
C, Citigroup — Citi’s transformation narrative remains intact, but the Dubai office exit highlighted that global operating risk management is becoming part of the turnaround story. Investors will increasingly judge Citi on whether simplification can coexist with international growth ambitions.
BAC, Bank of America — Berkshire’s trim of BAC remains a notable sentiment overhang, even as Bank of America’s own operating metrics in capital markets and digital engagement remain healthy. The broader implication is that large-cap bank ownership is becoming more selective, not sector-wide bullish.
ALL, Allstate — Allstate’s earnings momentum and cheap valuation made it one of the strongest traditional insurers in the news flow. It matters because it supports a rotation toward profitable, undervalued insurers with clean underwriting trends.
CINF, Cincinnati Financial — Cincinnati Financial’s sub-86 combined ratio and earnings beat reinforced that best-in-class underwriting still commands room for re-rating. This is a broader positive read-through for disciplined P&C names.
AJG, Arthur J. Gallagher — Gallagher’s continued double-digit growth and analyst upgrade supported the idea that insurance brokers can use AI as a margin enhancer rather than a disruptor. That matters for the whole brokerage space.
DFS, Discover Financial Services — Discover’s upward earnings revisions and inexpensive valuation made it one of the cleaner GARP-like stories in consumer finance. The setup matters particularly as investors reassess where to find earnings momentum without excessive multiple risk.
AMP, Ameriprise Financial — Ameriprise’s low multiple, rising book value, and buybacks reinforced the idea that high-quality wealth managers remain underappreciated in a market crowded by AI trades.
COF, Capital One — Capital One’s strategic optionality tied to Discover integration remains a major catalyst, but execution risk remains central. This matters because consumer finance M&A synergies are increasingly being scrutinized rather than simply applauded.
FIGR, Figure Technology Solutions — Figure’s move into auto loans and rapid earnings growth gave the fintech group one of its more tangible growth stories. It matters because the market continues to reward fintechs with visible TAM expansion and profitability improvement.
CRCL, Circle Internet Group — Circle’s rally remains tied to stablecoin adoption and institutional integration, but valuation is becoming the key debate. The broader significance is that payments and digital-dollar infrastructure remain investable themes, though no longer cheaply.
COIN, Coinbase — Coinbase’s collapsing earnings estimates and high multiple reinforced the market’s concern that crypto beta without stable earnings support is vulnerable, even amid broader institutional digital asset progress.

Watch:

Private credit liquidity and valuation discipline across JPM, BX, APO, ARES, and KKR — this is now a sector-level risk, not an isolated headline cycle.
Capital return and execution at C, BAC, DFS, AMP, and COF — with multiples still selective, the next leg for financials likely depends on clean earnings delivery and visible balance-sheet strength.

Healthcare

Theme: Healthcare news flow was defined by pipeline inflection points, regulatory and legal overhangs, and a renewed focus on companies proving they can convert scientific leadership into durable commercial growth. The day also reinforced a split between defensive large-cap healthcare cash generators and higher-beta biopharma names with binary catalysts.

Movers:

ABBV, AbbVie — AbbVie’s continued execution post-Humira and its advancing neuroscience pipeline reinforced its status as a rare large-cap biopharma successfully replacing a blockbuster patent cliff with real innovation. That matters because it validates AbbVie’s model as both a defensive and growth healthcare holding.
MRK, Merck — Merck’s upcoming Winrevair readout in pulmonary hypertension is a major swing factor in the company’s diversification story beyond oncology. It matters because a positive result could become a material new growth engine, while a miss would intensify concerns around dependence on existing blockbusters.
UTHR, United Therapeutics — The strong TETON-2 IPF data positions nebulized Tyvaso as a potentially practice-changing pulmonary therapy. This matters because it could materially expand United Therapeutics’ franchise and alter the pulmonary fibrosis treatment landscape.
VRTX, Vertex Pharmaceuticals — Vertex’s strong Phase 3 RAINER data in IgA nephropathy reinforced the market’s view that the company can build meaningful growth beyond cystic fibrosis. The read-through is important for large-cap biotech sentiment and premium biotech multiples.
DXCM, DexCom — DexCom’s evidence supporting CGM use in non-insulin type 2 diabetes is a major step toward expanding reimbursement and addressable market size. This is one of the stronger medtech growth stories because payer and physician adoption could meaningfully widen over time.
ISRG, Intuitive Surgical — Intuitive continued to look like the highest-quality robotics franchise in medtech, with strong da Vinci placements and broad procedure growth. It matters because hospital capex is still rewarding must-have platforms, not just incremental devices.
ALNY, Alnylam Pharmaceuticals — Alnylam’s partnership with Tenaya reinforces its position as a platform company in genetic medicines, not just a single-pipeline biotech. Strategic partnering at this scale matters because it extends the market’s confidence in Alnylam’s RNAi capabilities.
BBIO, BridgeBio Pharma — BridgeBio’s Phase 3 update and FDA encouragement for traditional approval made this one of the day’s clearest late-stage biotech catalysts. It matters because regulatory validation can rapidly change the market’s treatment of a rare-disease story from speculative to commercial.
NTRA, Natera — Citi naming Natera its top diagnostics pick after a sharp earnings beat points to a re-rating narrative around diagnostics names finally proving profitability discipline. This matters for the broader diagnostics group, which has struggled for sponsorship.
CRL, Charles River Laboratories — Citi’s upgrade of Charles River as a recovery name suggests selective optimism in CROs where bookings are stabilizing and biotech spending is expected to improve.
IQV, IQVIA — IQVIA’s acquisition of Charles River assets showed a more ambitious push into earlier-stage development services. The broader significance is that CROs are trying to become full-lifecycle partners, but integration risk remains central.
BSX, Boston Scientific — Boston Scientific’s strong fundamentals were overshadowed by litigation alleging disclosure failures in electrophysiology. This matters because premium medtech multiples can come under pressure quickly when governance credibility is questioned.
CVS, CVS Health — CVS’s Medicare coding settlement adds another layer of scrutiny to managed care and diversified healthcare companies. It matters because regulatory credibility is increasingly central to how investors value payer-adjacent earnings streams.
NVO, Novo Nordisk — Novo’s FDA warning letter is significant because regulatory process discipline matters more when companies are central to major therapeutic categories like GLP-1s. The stock’s valuation support increasingly depends on confidence that operational controls remain strong.
BMY? not in source; omitted.
AMGN, Amgen — Amgen’s challenge remains the same: legacy asset erosion versus pipeline replacement under a large debt load. Today’s framing matters because the market is less willing to grant defensive premium status to biopharma names without clean growth visibility.
GILD, Gilead — Gilead’s durable HIV franchise remains a stabilizer, but oncology setbacks remind investors that pipeline diversification remains unfinished. The stock is still treated more as a cash-flow franchise than a broad biotech growth platform.
JNJ, Johnson & Johnson — J&J’s defensive income appeal remains intact, but its meaningful future upside still ties back to pipeline durability and medtech consistency, particularly around oncology and immunology.
ABT, Abbott Laboratories — Abbott remains a healthcare defensive with strategic optionality tied to diagnostics and pathology. The Exact Sciences acquisition theme matters because it could tilt Abbott toward a more meaningful growth profile in oncology diagnostics.

Watch:

Clinical and regulatory readouts at MRK, ABBV, BBIO, UTHR, and VRTX — today reinforced that pipeline catalysts are the real valuation drivers across biopharma.
Regulatory and litigation risk around CVS, BSX, and NVO — in a market willing to pay for quality healthcare earnings, credibility and compliance matter more than ever.

Industrials

Theme: Industrials news flow centered on infrastructure modernization, defense-tech retooling, and selective market skepticism around valuation versus execution. The strongest narratives were attached to companies tied to power, defense, security, and modernization themes, while lower-conviction names saw the market punish weak guidance or stretched multiples.

Movers:

CAT, Caterpillar — Caterpillar’s $840 million framework agreement with Atlas Energy Solutions reinforced its push into distributed power and energy infrastructure, extending its relevance beyond traditional heavy equipment. This matters because CAT is increasingly seen as a beneficiary of AI-related power demand and industrial electrification.
GE, GE Aerospace — GE’s planned $1 billion U.S. manufacturing investment sharpened the market’s focus on aerospace supply-chain localization and scale. It matters because GE is staking out a stronger position in both commercial aviation recovery and defense-adjacent production readiness.
HON, Honeywell — Honeywell’s aerospace separation and associated financing indicate a major strategic redesign, with the market increasingly focused on whether the company can unlock value through simplification without taking on excessive execution risk.
BAH, Booz Allen Hamilton — Booz Allen’s investment in Hadean highlighted the increasingly important role of AI-enabled simulation, synthetic training, and defense software ecosystems. This matters because BAH is broadening from contractor to defense innovation platform.
BWXT, BWX Technologies — BWXT’s role in Bulgaria’s Kozloduy nuclear project reinforced its positioning as a practical beneficiary of the nuclear renaissance, especially outside the speculative SMR trade. Investors are rewarding names tied to real project execution over concept-stage exposure.
BWXT also stands out because nuclear engineering demand is becoming more global, not purely domestic.
AVAV, AeroVironment — AeroVironment’s goodwill writedown and contract loss highlighted the risks of overextension even in favored defense-tech segments. It matters because investors are no longer willing to ignore program execution failures simply because a company is drone-exposed.
KTOS, Kratos Defense — Kratos’ contract wins in drones and simulation reinforced the market’s appetite for cost-effective, unmanned defense platforms. This matters because the market is rewarding names with direct exposure to autonomous systems demand.
GD, General Dynamics — General Dynamics’ backlog and strategic relevance in cyber and military systems continue to support the view that large-cap defense can still offer both stability and upside.
LHX, L3Harris Technologies — L3Harris remains one of the cleaner large-cap defense momentum stories, particularly as investors continue to favor names tied to communications, sensing, and mission systems over slower-moving legacy programs.
CW, Curtiss-Wright — Curtiss-Wright’s role in naval nuclear infrastructure reinforces its value as a specialized defense supplier with long-duration demand visibility.
AME, AMETEK — AMETEK’s dividend hike and durable earnings profile support the view that quality specialty industrials remain attractive even in a market obsessed with AI.
ALLE, Allegion — Allegion’s upcoming investor presentation has become a watch item because investors want evidence that it can become a higher-multiple digital security platform, not just a hardware business.
FIX, Comfort Systems USA — Massive earnings revisions and strength tied to HVAC/electrical infrastructure suggest Comfort is still one of the market’s best pure plays on commercial buildout and data-center-related mechanical demand.
GNRC, Generac — Generac’s upcoming investor day matters because investors want clarity on whether the company can become a broader energy infrastructure and storage story, not just a generator business.
APD, Air Products — Air Products’ investor conference setup keeps attention on hydrogen strategy, but the market needs clearer evidence that clean hydrogen capex can translate into durable returns.

Watch:

Capital-spending conversion into earnings at CAT, GE, HON, and GNRC — industrial investors are rewarding visible execution, not just strategic slides.
Defense-tech momentum in KTOS, BAH, BWXT, LHX, and AVAV — the next leg depends on contract conversion and program reliability, not just geopolitical headlines.

Energy

Theme: Energy remains dominated by geopolitical supply risk and the race to secure reliable power for AI, LNG, and industrial demand. The day’s news underscored two parallel stories: oil and LNG names levered to Middle East disruption, and power/infrastructure companies being re-rated as critical enablers of AI and energy security.

Movers:

APA, APA Corp — APA’s rally remains tightly linked to Middle East escalation and the threat to the Strait of Hormuz. This matters because the stock is functioning as a high-beta crude expression, making it attractive tactically but highly exposed to any de-escalation.
DVN, Devon Energy — Devon’s setup similarly reflects the market’s appetite for pure upstream oil beta with strong free cash flow leverage. The key significance is that the market is rewarding companies where higher crude immediately converts to shareholder economics.
VLO, Valero Energy — Valero’s outsized move showed refiners still act as one of the best ways to play energy volatility and product margin expansion. This matters because investors are increasingly differentiating between upstream price leverage and downstream margin leverage.
MPC, Marathon Petroleum — Marathon’s strength further reinforced the same refining theme: geopolitical disruption is feeding directly into refining equity outperformance.
OXY, Occidental Petroleum — Occidental’s improved fair value narrative and disciplined capital guidance suggest the market is warming to cash generation plus shareholder return stories in large-cap oil.
CVX, Chevron — Chevron’s Venezuelan expansion plans are strategically significant because they show supermajors are still willing to pursue politically complex, low-cost reserve additions in a world short of easy barrels.
SHEL, Shell — Shell’s move into Venezuela fits the same broader story of majors chasing advantaged barrels despite elevated geopolitical risk. This matters because reserve replacement and political risk tolerance are back in focus.
LNG, Cheniere / LNG exposure — Qatar’s Ras Laffan disruption was among the day’s most important macro energy developments. It matters because it challenged assumptions about post-2026 LNG oversupply and immediately tightened the market’s supply-risk calculus.
VG, Venture Global — Venture Global is emerging as a tactical beneficiary of the LNG disruption thesis, with the market increasingly looking for U.S. export winners if Qatari supply remains constrained.
EQNR, Equinor — Equinor’s string of North Sea discoveries reinforced confidence in infrastructure-led, lower-risk exploration strategies, especially in Europe’s energy security context.
BKR, Baker Hughes — Baker Hughes’ growing optimism and possible Waygate sale reinforce the market’s preference for oilfield names with a cleaner path toward energy-transition or digital adjacencies.
BE, Bloom Energy — Bloom is gaining traction as a prime beneficiary of AI-driven power demand, with increasing relevance in on-site and modular generation. This matters because AI’s power intensity is broadening the investable energy universe beyond utilities and hydrocarbons.
INTC, Intel and AEP, American Electric Power / BE, Bloom Energy — The Intel-Bloom and AEP-Bloom partnerships reinforced a critical trend: data-center power reliability is becoming a central equity theme across both energy and technology.
CEG, Constellation Energy — NRC approval at Limerick provided one of the strongest examples of how existing nuclear infrastructure is being revalued as a scalable answer to AI-era power demand.
NEE, NextEra Energy — NextEra’s generation backlog and Google-linked nuclear restart narrative support its status as one of the cleanest ways to play AI power demand through a utility lens.
AES, AES Corp — AES remains one of the more direct AI-related renewable and gas-linked power stories, but balance-sheet leverage remains the key investor concern.
ATO, Atmos Energy — Atmos’ capex plan reflects ongoing investor appetite for regulated gas infrastructure modernization, especially where reliability and grid hardening are central themes.

Watch:

Middle East supply risk and LNG repricing through APA, DVN, VLO, MPC, CVX, SHEL, LNG, and VG — this remains the biggest macro driver for near-term energy equity performance.
AI power demand and utility/power infrastructure monetization through BE, CEG, NEE, AES, AEP, and INTC-adjacent energy partnerships.

Utilities

Theme: Utilities are increasingly being split between traditional income plays and a faster-growing subset being revalued as AI power and grid modernization beneficiaries. Today’s news leaned heavily toward utilities with clear capex pipelines, partnerships, or direct links to data-center demand.

Movers:

NEE, NextEra Energy — NextEra’s scale, generation backlog, and strategic projects tied to AI and data-center power demand reinforced its role as a premium utility growth platform. The market continues to reward utilities that can credibly convert capex into long-duration earnings growth.
CEG, Constellation Energy — NRC approval at Limerick is one of the strongest sector catalysts of the day, because it shows existing nuclear fleets can be upgraded and monetized as AI-era baseload assets. This is a meaningful differentiator versus purely conceptual nuclear trades.
AEP, American Electric Power — AEP’s partnership with Bloom Energy put it squarely in the conversation around decentralized power for data centers, a theme that is becoming increasingly relevant for utility valuation.
DUK, Duke Energy — Duke’s financing and Florida capex plan continue to underscore that large regulated utilities with credible infrastructure investment pipelines may command a valuation premium even in a rate-sensitive environment.
CMS, CMS Energy — CMS remains a more traditional utility story, but the Michigan resource-plan decision has become an important watch item because it could affect the balance between growth, regulation, and ESG credibility.
PPL, PPL Corp — PPL’s stock momentum and dividend profile suggest investors are increasingly treating it as a data-center demand utility beneficiary, not simply a defensive income name.
ATO, Atmos Energy — Atmos continues to stand out for its infrastructure modernization capex, supporting the thesis that gas distribution names can still win capital if they tie spending to reliability and demand growth.
AWK, American Water Works — AWK remains more of a social-license and regulatory-goodwill story, but that still matters in utility investing because rate-case outcomes and public trust are material valuation drivers.
AEE, Ameren — Ameren’s role remains largely income-oriented, but within the current utility tape, names without an obvious AI/grid growth hook are likely to trade more on rates and dividend durability than on multiple expansion.

Watch:

Regulatory and capex execution at DUK, CMS, ATO, and PPL — the utilities with the most upside are the ones proving they can turn infrastructure spend into predictable earnings.
AI and data-center electricity demand as a re-rating force for NEE, CEG, AEP, and PPL.

Transportation

Theme: Transportation was dominated by a clear divergence between rail/logistics operators showing operational discipline and airlines facing an increasingly hostile cost and service environment. The day’s news made plain that fuel exposure, hedging discipline, and demand quality are now central sorting mechanisms within the group.

Movers:

UAL, United Airlines — United’s solid recent operating performance is being overshadowed by its unhedged fuel exposure just as Middle East tensions drive jet fuel sharply higher. This matters because the market is moving from admiring demand recovery to questioning margin protection.
DAL, Delta Air Lines — Delta’s fuel exposure and TSA-related service chaos reinforced the same concern. Even with better operational